931 related articles for article (PubMed ID: 18925580)
1. The utility of detailed first trimester ultrasound examination in abnormal fetal nuchal translucency.
Bronshtein M; Zimmer EZ; Blazer S
Prenat Diagn; 2008 Nov; 28(11):1037-41. PubMed ID: 18925580
[TBL] [Abstract][Full Text] [Related]
2. Increased nuchal translucency thickness and normal karyotype: time for parental reassurance.
Bilardo CM; Müller MA; Pajkrt E; Clur SA; van Zalen MM; Bijlsma EK
Ultrasound Obstet Gynecol; 2007 Jul; 30(1):11-8. PubMed ID: 17559183
[TBL] [Abstract][Full Text] [Related]
3. Association of fetal choroid plexus cysts with trisomy 18 in a population previously screened by nuchal translucency thickness measurement.
Cheng PJ; Shaw SW; Soong YK
J Soc Gynecol Investig; 2006 May; 13(4):280-4. PubMed ID: 16697944
[TBL] [Abstract][Full Text] [Related]
4. First-trimester ultrasonographic screening for trisomy 21 using fetal nuchal translucency and nasal bone.
Sepulveda W; Wong AE; Dezerega V
Obstet Gynecol; 2007 May; 109(5):1040-5. PubMed ID: 17470580
[TBL] [Abstract][Full Text] [Related]
5. Sonographic screening for trisomy 13 at 11 to 13(+6) weeks of gestation.
Papageorghiou AT; Avgidou K; Spencer K; Nix B; Nicolaides KH
Am J Obstet Gynecol; 2006 Feb; 194(2):397-401. PubMed ID: 16458636
[TBL] [Abstract][Full Text] [Related]
6. [Prospective cohort study of fetal nuchal translucency in first-trimester and pregnancy outcome].
Tang HR; Zhang Y; Ru T; Li J; Yang L; Xu Y; Duan HL; Wang Y; Wang Y; Hu YL; Zhang Y; Zheng MM
Zhonghua Fu Chan Ke Za Zhi; 2020 Feb; 55(2):94-99. PubMed ID: 32146737
[No Abstract] [Full Text] [Related]
7. First trimester ultrasonography in screening and detection of fetal anomalies.
Sonek J
Am J Med Genet C Semin Med Genet; 2007 Feb; 145C(1):45-61. PubMed ID: 17304542
[TBL] [Abstract][Full Text] [Related]
8. [First trimester nuchal translucency thickness in normal fetuses in the Bulgarian population].
Markov D; Chernev T; Dimitrova V; Mazneŭkova V
Akush Ginekol (Sofiia); 2005; 44(5):3-8. PubMed ID: 16313046
[TBL] [Abstract][Full Text] [Related]
9. Structural heart defects associated with an increased nuchal translucency: 9 years experience in a referral centre.
Clur SA; Mathijssen IB; Pajkrt E; Cook A; Laurini RN; Ottenkamp J; Bilardo CM
Prenat Diagn; 2008 Apr; 28(4):347-54. PubMed ID: 18382996
[TBL] [Abstract][Full Text] [Related]
10. First-trimester screening for chromosomal abnormalities.
Nicolaides KH
Semin Perinatol; 2005 Aug; 29(4):190-4. PubMed ID: 16104667
[TBL] [Abstract][Full Text] [Related]
11. Screening for fetal chromosomal abnormalities with nuchal translucency measurement in the first trimester.
Has R; Kalelioglu I; Ermis H; Ibrahimoglu L; Yuksel A; Yildirim A; Basaran S
Fetal Diagn Ther; 2006; 21(4):355-9. PubMed ID: 16757911
[TBL] [Abstract][Full Text] [Related]
12. Long-term outcome for children born after a first-trimester measurement of increased nuchal translucency with a normal karyotype: a retrospective analysis.
Axt-Fliedner R; Hartge D; Chiriac A; Krapp M; Berg C; Geipel A; Germer U; Gembruch U
Ultraschall Med; 2009 Dec; 30(6):558-63. PubMed ID: 19137496
[TBL] [Abstract][Full Text] [Related]
13. First-trimester screening for trisomies 18 and 13, triploidy and Turner syndrome by detailed early anomaly scan.
Wagner P; Sonek J; Hoopmann M; Abele H; Kagan KO
Ultrasound Obstet Gynecol; 2016 Oct; 48(4):446-451. PubMed ID: 26611869
[TBL] [Abstract][Full Text] [Related]
14. Increased nuchal translucency and normal karyotype: perinatal and pediatric outcomes at 2 years of age.
Mula R; Goncé A; Bennásar M; Arigita M; Meler E; Nadal A; Sánchez A; Botet F; Borrell A
Ultrasound Obstet Gynecol; 2012 Jan; 39(1):34-41. PubMed ID: 21837766
[TBL] [Abstract][Full Text] [Related]
15. Should cell-free DNA testing be used in pregnancy with increased fetal nuchal translucency?
Miranda J; Paz Y Miño F; Borobio V; Badenas C; Rodriguez-Revenga L; Pauta M; Borrell A
Ultrasound Obstet Gynecol; 2020 May; 55(5):645-651. PubMed ID: 31301176
[TBL] [Abstract][Full Text] [Related]
16. [Ultrasound screening for Down syndrome and other chromosomal abnormalities by fetal nuchal translucency measurement between 11-14 weeks of gestation].
Dimitrova V; Markov D; Chernev T; Karag'ozova Zh; Mazneĭkova V; Andonova S; Vŭzharova R
Akush Ginekol (Sofiia); 2005; 44(1):32-7. PubMed ID: 15853009
[TBL] [Abstract][Full Text] [Related]
17. Submicroscopic chromosomal abnormalities in fetuses with increased nuchal translucency and normal karyotype.
Yang X; Li R; Fu F; Zhang Y; Li D; Liao C
J Matern Fetal Neonatal Med; 2017 Jan; 30(2):194-198. PubMed ID: 26998667
[TBL] [Abstract][Full Text] [Related]
18. [Screening for Down syndrome using first-trimester combined screening followed by second trimester ultrasound examination in an unselected population].
Rozenberg P; Bussières L; Chevret S; Bernard JP; Malagrida L; Cuckle H; Chabry C; Durand-Zaleski I; Bidat L; Lacroix I; Moulis M; Roger M; Jacquemot MC; Bault JP; Boukobza P; Boccara P; Vialat F; Giudicelli Y; Ville Y
Gynecol Obstet Fertil; 2007 Apr; 35(4):303-11. PubMed ID: 17350315
[TBL] [Abstract][Full Text] [Related]
19. [A proposed protocol for obstetrical ultrasound examination].
Novakov A; Vejnović T; Stojić S; Belopavlović Z
Med Pregl; 1999; 52(9-10):351-6. PubMed ID: 10624383
[TBL] [Abstract][Full Text] [Related]
20. Fetal thickened nuchal soft tissues may first appear in the second trimester in Down syndrome.
Zimmer EZ; Blazer S; Linn S; Bronshtein M
J Clin Ultrasound; 2010 Feb; 38(2):71-4. PubMed ID: 19830827
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
